Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shanu Modi

Showing results (21-30 of 115) with videos related to

Pageof 12
Sort By:
Cancer|September 1, 2005
Incidence of chemotherapy-induced, long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxaneMonica N Fornier, Shanu Modi, Katherine S Panageas, et al.
Breast Cancer Research and Treatment|November 27, 2025
Evaluating post-T-DXd treatment strategies in HER2-positive metastatic breast cancerSophia Zelizer, Grace B Gallagher, Mithat Gonen, et al.
Breast (Edinburgh, Scotland)|March 3, 2026
Real-world treatment patterns and outcomes in HER2-low, HR+ metastatic breast cancer patients previously treated with endocrine therapy in the United StatesShanu Modi, Danalyn Byng, Suyuan Zhang, et al.
Therapeutic Advances in Medical Oncology|June 16, 2023
Targeting HER2-low in metastatic breast cancer: an evolving treatment paradigmCharlie Yang, Christine Brezden-Masley, Anil Abraham Joy, et al.
Breast Cancer Research and Treatment|March 25, 2025
Treatment patterns and outcomes in HER2-low metastatic breast cancer patients previously treated with chemotherapy: a US real-world cohort studyShanu Modi, Suyuan Zhang, Danalyn Byng, et al.
The Journal of Biological Chemistry|November 10, 2018
Chaperome heterogeneity and its implications for cancer study and treatmentTai Wang, Anna Rodina, Mark P Dunphy, et al.
Clinical Breast Cancer|September 1, 2006
A phase I study of cetuximab/paclitaxel in patients with advanced-stage breast cancerShanu Modi, Gabriella D'Andrea, Larry Norton, et al.
Journal of Visualized Experiments : Jove|October 29, 2014
Ex vivo treatment response of primary tumors and/or associated metastases for preclinical and clinical development of therapeuticsAdriana D Corben, Mohammad M Uddin, Brooke Crawford, et al.
JAMA Dermatology|April 12, 2018
Endocrine Therapy-Induced Alopecia in Patients With Breast CancerAzael Freites-Martinez, Jerry Shapiro, Donald Chan, et al.
Breast Cancer Research and Treatment|June 16, 2014
Ado-trastuzumab emtansine-associated telangiectasias in metastatic breast cancer: a case seriesVincent Sibaud, Rachel E Niec, Katja Schindler, et al.
Pageof 12

Showing results (21-30 of 115) with videos related to

Sort By:
Pageof 12
Cancer|September 1, 2005
Incidence of chemotherapy-induced, long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxaneMonica N Fornier, Shanu Modi, Katherine S Panageas, et al.
Breast Cancer Research and Treatment|November 27, 2025
Evaluating post-T-DXd treatment strategies in HER2-positive metastatic breast cancerSophia Zelizer, Grace B Gallagher, Mithat Gonen, et al.
Breast (Edinburgh, Scotland)|March 3, 2026
Real-world treatment patterns and outcomes in HER2-low, HR+ metastatic breast cancer patients previously treated with endocrine therapy in the United StatesShanu Modi, Danalyn Byng, Suyuan Zhang, et al.
Therapeutic Advances in Medical Oncology|June 16, 2023
Targeting HER2-low in metastatic breast cancer: an evolving treatment paradigmCharlie Yang, Christine Brezden-Masley, Anil Abraham Joy, et al.
Breast Cancer Research and Treatment|March 25, 2025
Treatment patterns and outcomes in HER2-low metastatic breast cancer patients previously treated with chemotherapy: a US real-world cohort studyShanu Modi, Suyuan Zhang, Danalyn Byng, et al.
The Journal of Biological Chemistry|November 10, 2018
Chaperome heterogeneity and its implications for cancer study and treatmentTai Wang, Anna Rodina, Mark P Dunphy, et al.
Clinical Breast Cancer|September 1, 2006
A phase I study of cetuximab/paclitaxel in patients with advanced-stage breast cancerShanu Modi, Gabriella D'Andrea, Larry Norton, et al.
Journal of Visualized Experiments : Jove|October 29, 2014
Ex vivo treatment response of primary tumors and/or associated metastases for preclinical and clinical development of therapeuticsAdriana D Corben, Mohammad M Uddin, Brooke Crawford, et al.
JAMA Dermatology|April 12, 2018
Endocrine Therapy-Induced Alopecia in Patients With Breast CancerAzael Freites-Martinez, Jerry Shapiro, Donald Chan, et al.
Breast Cancer Research and Treatment|June 16, 2014
Ado-trastuzumab emtansine-associated telangiectasias in metastatic breast cancer: a case seriesVincent Sibaud, Rachel E Niec, Katja Schindler, et al.
Pageof 12